Market Closed - OTC Markets 03:59:59 2024-03-28 pm EDT 5-day change 1st Jan Change
7.7 USD -1.28% Intraday chart for Veradigm Inc. -1.28% -26.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15 MT
Transcript : Veradigm Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 02:05 PM
Veradigm Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Veradigm Inc. completed the acquisition of Cascade Bio, Inc CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P 600 Health Care CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P 600 CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P Composite 1500 CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P Global BMI Index CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P 1000 CI
Veradigm Inc.(OTCPK:MDRX) dropped from S&P TMI Index CI
Veradigm Inc.(OTCPK:MDRX) dropped from NASDAQ Composite Index CI
Veradigm to Buy ScienceIO for $140 Million; Expects Nasdaq Delisting Notice; Shares Fall MT
Veradigm Inc. signed a definitive agreement to acquire Cascade Bio, Inc. CI
Veradigm Inc. and Veradigm LLC Enter into an Amendment to the Third Amended and Restated Credit Agreement CI
RBC Halves Price Target on Veradigm to $11 From $22, Keeps Outperform Rating MT
Transcript : Veradigm Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11:15 AM
Veradigm Expects Lower Fiscal 2023 Non-GAAP Earnings, Revenue MT
Veradigm Inc. Revises Earnings Guidance for the Fiscal 2023 CI
Veradigm Picks MedAllies as Qualified Health Information Network Partner MT
Barclays Starts Allscripts Healthcare Solutions With Equalweight Rating, $11 Price Target MT
Veradigm Acquires Koha Health MT
Veradigm Inc. acquired Koha Health, LLC. CI
Wall Street Futures Lean Lower Premarket Thursday; Volumes Remain Thin Towards Year-End MT
Veradigm to Continue to Be Listed Subject to Demonstrating Compliance With Nasdaq Rules MT
Veradigm Inc. to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing Services CI
Chart Veradigm Inc.
More charts
Veradigm Inc. is a healthcare data and technology solutions technology company. The Company is focused on research, analytics, and building scalable data-driven solutions. It combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. It also provides full-service revenue cycle management.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.7 USD
Average target price
15 USD
Spread / Average Target
+94.81%
Consensus
  1. Stock
  2. Equities
  3. Stock Veradigm Inc. - OTC Markets
  4. News Veradigm Inc.
  5. Allscripts Healthcare : BofA Securities Adjusts Allscripts Healthcare Solutions PT to $16.50 From $14, Maintains Buy Rating